Company intelligence / Profile preview
Bukwang Pharmaceutical
- Ownership
- Private
- Employees
- ~614
- Development stage
- Commercial
Overview
Bukwang Pharmaceutical is a leading South Korean pharmaceutical company with over six decades of history. It has a strong focus on central nervous system diseases such as schizophrenia and bipolar disorder. The company has successfully commercialized several drugs—including Latuda®—and maintains an active pipeline targeting neurological disorders and oncology. Recent clinical milestones include positive Phase III results for key CNS programs and regulatory approvals in Korea. The firm leverages both internal R&D capabilities and external collaborations to expand its portfolio globally.[1][3]
- Therapeutic areas
- OncologyEndocrinologyPsychiatryNeurology
- Modalities
- Small molecules[6]Chemical drugs[6]Combination drugs (e.g., donepezil/memantine)[6]
- Industry
- Biotech
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Bukwang Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bukwang Pharmaceutical.